Skip to content
healthcare.dev

UDENYCA

NDC 70114-101, pegfilgrastim-cbqv, injection, solution, from Coherus Oncology, Inc..

Product NDC
70114-101
Status
Listed
Labeler
Coherus Oncology, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761039
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70114-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGFILGRASTIM6 mg/.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
70114-101-01701140101011 SYRINGE in 1 CARTON (70114-101-01) / .6 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a8c290ee-b699-4395-a596-1453d4a4b4eb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70114-101

Use it

Look up 70114-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70114-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70114-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.